ProKidney Historical Cash Flow
| PROK Stock | USD 1.46 0.04 2.67% |
Analysis of ProKidney Corp cash flow over time is an excellent tool to project ProKidney Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 126.7 M or Other Cashflows From Investing Activities of 64.8 K as it is a great indicator of ProKidney Corp ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining ProKidney Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ProKidney Corp is a good buy for the upcoming year.
ProKidney |
About ProKidney Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ProKidney balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ProKidney's non-liquid assets can be easily converted into cash.
ProKidney Corp Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by ProKidney Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of ProKidney Corp operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from ProKidney Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ProKidney Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.At this time, ProKidney Corp's Begin Period Cash Flow is quite stable compared to the past year.
| 2021 | 2022 | 2024 | 2025 (projected) | Change To Liabilities | 7.9M | 772K | 887.8K | 843.4K | Change To Netincome | 699K | 74.5M | 85.6M | 89.9M |
ProKidney Corp cash flow statement Correlations
Click cells to compare fundamentals
ProKidney Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ProKidney Corp cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (10.6M) | 16.0M | 469.7M | (429.6M) | (386.6M) | (367.3M) | |
| Stock Based Compensation | 730.0 | 699.0 | 74.5K | 30.8M | 35.5M | 37.2M | |
| Free Cash Flow | (30.6M) | (55.5M) | (78.9M) | (124.3M) | (111.8M) | (106.2M) | |
| Change In Working Capital | (126K) | 2.2M | (6.5M) | 16.7M | 19.2M | 20.1M | |
| Other Cashflows From Financing Activities | 20M | 71.5M | 548.6M | (330.0M) | (297.0M) | (282.1M) | |
| Depreciation | 964K | 2.0M | 3.0M | 3.2M | 3.6M | 2.0M | |
| Other Non Cash Items | 604.0 | 4.7M | 40.4M | (5.3M) | (6.1M) | (5.8M) | |
| Capital Expenditures | 5.5M | 5.2M | 1.8M | 34.2M | 39.3M | 41.3M | |
| Total Cash From Operating Activities | (25.2M) | (50.3M) | (77.1M) | (90.1M) | (81.1M) | (77.0M) | |
| Net Income | (26.7M) | (55.1M) | (148.1M) | (135.4M) | (121.9M) | (115.8M) | |
| Total Cash From Financing Activities | 20.0M | 71.5M | 548.5M | (9.6M) | (11.0M) | (10.4M) | |
| End Period Cash Flow | 4.6M | 20.6M | 490.3M | 60.6M | 69.7M | 126.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.